Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):204-212. doi: 10.1111/bcpt.13533. Epub 2020 Nov 22.
Basic Clin Pharmacol Toxicol. 2021.
PMID: 33176395
Free article.
Review.